JP Stock MarketDetailed Quotes

4527 Rohto Pharmaceutical

Watchlist
  • 2385.0
  • +13.0+0.55%
20min DelayNot Open Apr 30 15:30 JST
563.29BMarket Cap17.64P/E (Static)

Rohto Pharmaceutical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
Total revenue
18.44%86.81B
11.75%68.36B
13.48%270.84B
11.66%69.68B
11.14%73.29B
14.88%66.7B
17.06%61.17B
19.54%238.66B
12.18%62.4B
24.43%65.95B
Cost of revenue
21.75%36.32B
15.28%29.28B
12.16%113.55B
12.86%29.81B
10.52%29.83B
13.25%28.51B
12.09%25.4B
21.28%101.24B
13.93%26.42B
24.51%27B
Gross profit
16.18%50.49B
9.24%39.08B
14.45%157.29B
10.78%39.87B
11.56%43.46B
16.13%38.19B
20.87%35.77B
18.29%137.42B
10.93%35.99B
24.37%38.96B
Operating expense
23.49%36.01B
11.46%27.29B
13.32%117.23B
14.56%35.08B
9.53%29.16B
14.46%28.51B
14.93%24.48B
18.71%103.46B
14.39%30.62B
22.54%26.63B
Staff costs
----
----
7.52%22.01B
----
----
----
----
11.37%20.47B
----
----
Selling and administrative expenses
----
----
16.68%54.22B
----
----
----
----
21.92%46.47B
----
----
-Selling and marketing expense
----
----
16.68%54.22B
----
----
----
----
21.92%46.47B
----
----
Research and development costs
----
----
21.01%13.39B
----
----
----
----
26.60%11.07B
----
----
Depreciation and amortization
----
----
3.59%2.42B
----
----
----
----
10.70%2.34B
----
----
-Depreciation
----
----
1.58%1.99B
----
----
----
----
18.12%1.96B
----
----
-Amortization
----
----
13.84%436M
----
----
----
----
-16.19%383M
----
----
Other operating expenses
----
----
8.98%25.19B
----
----
----
----
16.73%23.12B
----
----
Operating profit
1.27%14.48B
4.41%11.79B
17.92%40.05B
-10.75%4.79B
15.95%14.3B
21.33%9.67B
36.13%11.29B
17.04%33.96B
-5.41%5.37B
28.51%12.33B
Net non-operating interest income (expenses)
-145.89%-162M
38.52%374M
85.59%1.33B
54.89%412M
150.35%353M
160.71%292M
37.76%270M
495.83%715M
818.92%266M
138.98%141M
Non-operating interest income
-35.38%274M
38.92%439M
58.32%1.52B
34.17%428M
100.00%424M
99.44%355M
24.90%316M
161.41%962M
243.01%319M
103.85%212M
Non-operating interest expense
514.08%436M
41.30%65M
-20.65%196M
-69.81%16M
0.00%71M
-4.55%63M
-19.30%46M
-0.40%247M
-59.23%53M
57.78%71M
Net investment income
220.75%320M
12.45%289M
15.19%933M
28.97%463M
3.99%-265M
1.27%478M
0.78%257M
111.49%810M
232.96%359M
-263.31%-276M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
336.65%1.43B
-187.01%-221M
-274.18%-1.01B
-129.18%-164M
-4,120.00%-603M
53.33%-161M
-122.32%-77M
172.31%577M
345.41%562M
103.23%15M
Income from associates and other participating interests
664.71%96M
-98.65%1M
-259.67%-289M
-1,067.57%-358M
-121.25%-17M
-14.29%12M
48.00%74M
26.57%181M
5.71%37M
-54.02%80M
Special income (charges)
-123M
-157.72%-142M
0
0
0
29.91%-246M
2,833.33%246M
-24.49%-1.54B
-63.95%-1.39B
238.93%207M
Less:Other special charges
--0
---23M
----
----
----
----
----
219.53%153M
--0
--0
Less:Write off
--123M
167.07%165M
--0
----
----
24.24%246M
-2,833.33%-246M
-32.34%1.39B
----
----
Other non-operating income (expenses)
-29.66%185M
-98.89%2M
222.28%505M
56.22%-190M
133.67%263M
-12.50%252M
-64.98%180M
-267.89%-413M
-734.62%-434M
-642.36%-781M
Income before tax
15.64%16.22B
-1.21%12.09B
21.08%41.52B
3.88%4.95B
19.71%14.03B
26.23%10.3B
26.87%12.24B
23.02%34.29B
11.49%4.76B
22.99%11.72B
Income tax
2.25%4.42B
20.70%3.61B
28.79%10.12B
-50.00%84M
36.45%4.32B
40.74%2.73B
15.58%2.99B
17.56%7.86B
-46.15%168M
-5.55%3.17B
Net income
21.59%11.8B
-8.30%8.48B
18.79%31.39B
5.88%4.86B
13.49%9.71B
21.70%7.57B
31.03%9.25B
24.74%26.43B
15.98%4.59B
38.49%8.55B
Net income continuous operations
21.59%11.8B
-8.29%8.49B
18.79%31.4B
5.85%4.86B
13.51%9.71B
21.71%7.57B
31.01%9.25B
24.74%26.43B
16.04%4.6B
38.48%8.55B
Noncontrolling interests
-158.04%-83M
-99.38%1M
778.85%457M
158.62%85M
34.91%143M
209.09%68M
133.33%161M
-13.33%52M
-154.39%-145M
21.84%106M
Net income attributable to the company
24.28%11.89B
-6.69%8.48B
17.28%30.94B
0.82%4.78B
13.24%9.56B
21.01%7.5B
30.02%9.09B
24.85%26.38B
18.00%4.74B
38.72%8.45B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
24.28%11.89B
-6.69%8.48B
17.28%30.94B
0.82%4.78B
13.24%9.56B
21.01%7.5B
30.02%9.09B
24.85%26.38B
18.00%4.74B
38.72%8.45B
Gross dividend payment
Basic earnings per share
24.26%52.09
-6.70%37.18
17.29%135.61
0.82%20.95
13.27%41.92
21.01%32.89
30.02%39.85
24.85%115.62
18.00%20.78
38.69%37.01
Diluted earnings per share
24.28%51.95
-6.67%37.08
17.28%135.21
0.77%20.88
13.25%41.8
21.03%32.8
30.01%39.73
24.85%115.29
18.00%20.72
38.73%36.91
Dividend per share
0
0
22.73%27
25.00%15
0
20.00%12
0
22.22%22
14.29%12
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Dec 31, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022
Total revenue 18.44%86.81B11.75%68.36B13.48%270.84B11.66%69.68B11.14%73.29B14.88%66.7B17.06%61.17B19.54%238.66B12.18%62.4B24.43%65.95B
Cost of revenue 21.75%36.32B15.28%29.28B12.16%113.55B12.86%29.81B10.52%29.83B13.25%28.51B12.09%25.4B21.28%101.24B13.93%26.42B24.51%27B
Gross profit 16.18%50.49B9.24%39.08B14.45%157.29B10.78%39.87B11.56%43.46B16.13%38.19B20.87%35.77B18.29%137.42B10.93%35.99B24.37%38.96B
Operating expense 23.49%36.01B11.46%27.29B13.32%117.23B14.56%35.08B9.53%29.16B14.46%28.51B14.93%24.48B18.71%103.46B14.39%30.62B22.54%26.63B
Staff costs --------7.52%22.01B----------------11.37%20.47B--------
Selling and administrative expenses --------16.68%54.22B----------------21.92%46.47B--------
-Selling and marketing expense --------16.68%54.22B----------------21.92%46.47B--------
Research and development costs --------21.01%13.39B----------------26.60%11.07B--------
Depreciation and amortization --------3.59%2.42B----------------10.70%2.34B--------
-Depreciation --------1.58%1.99B----------------18.12%1.96B--------
-Amortization --------13.84%436M-----------------16.19%383M--------
Other operating expenses --------8.98%25.19B----------------16.73%23.12B--------
Operating profit 1.27%14.48B4.41%11.79B17.92%40.05B-10.75%4.79B15.95%14.3B21.33%9.67B36.13%11.29B17.04%33.96B-5.41%5.37B28.51%12.33B
Net non-operating interest income (expenses) -145.89%-162M38.52%374M85.59%1.33B54.89%412M150.35%353M160.71%292M37.76%270M495.83%715M818.92%266M138.98%141M
Non-operating interest income -35.38%274M38.92%439M58.32%1.52B34.17%428M100.00%424M99.44%355M24.90%316M161.41%962M243.01%319M103.85%212M
Non-operating interest expense 514.08%436M41.30%65M-20.65%196M-69.81%16M0.00%71M-4.55%63M-19.30%46M-0.40%247M-59.23%53M57.78%71M
Net investment income 220.75%320M12.45%289M15.19%933M28.97%463M3.99%-265M1.27%478M0.78%257M111.49%810M232.96%359M-263.31%-276M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets 336.65%1.43B-187.01%-221M-274.18%-1.01B-129.18%-164M-4,120.00%-603M53.33%-161M-122.32%-77M172.31%577M345.41%562M103.23%15M
Income from associates and other participating interests 664.71%96M-98.65%1M-259.67%-289M-1,067.57%-358M-121.25%-17M-14.29%12M48.00%74M26.57%181M5.71%37M-54.02%80M
Special income (charges) -123M-157.72%-142M00029.91%-246M2,833.33%246M-24.49%-1.54B-63.95%-1.39B238.93%207M
Less:Other special charges --0---23M--------------------219.53%153M--0--0
Less:Write off --123M167.07%165M--0--------24.24%246M-2,833.33%-246M-32.34%1.39B--------
Other non-operating income (expenses) -29.66%185M-98.89%2M222.28%505M56.22%-190M133.67%263M-12.50%252M-64.98%180M-267.89%-413M-734.62%-434M-642.36%-781M
Income before tax 15.64%16.22B-1.21%12.09B21.08%41.52B3.88%4.95B19.71%14.03B26.23%10.3B26.87%12.24B23.02%34.29B11.49%4.76B22.99%11.72B
Income tax 2.25%4.42B20.70%3.61B28.79%10.12B-50.00%84M36.45%4.32B40.74%2.73B15.58%2.99B17.56%7.86B-46.15%168M-5.55%3.17B
Net income 21.59%11.8B-8.30%8.48B18.79%31.39B5.88%4.86B13.49%9.71B21.70%7.57B31.03%9.25B24.74%26.43B15.98%4.59B38.49%8.55B
Net income continuous operations 21.59%11.8B-8.29%8.49B18.79%31.4B5.85%4.86B13.51%9.71B21.71%7.57B31.01%9.25B24.74%26.43B16.04%4.6B38.48%8.55B
Noncontrolling interests -158.04%-83M-99.38%1M778.85%457M158.62%85M34.91%143M209.09%68M133.33%161M-13.33%52M-154.39%-145M21.84%106M
Net income attributable to the company 24.28%11.89B-6.69%8.48B17.28%30.94B0.82%4.78B13.24%9.56B21.01%7.5B30.02%9.09B24.85%26.38B18.00%4.74B38.72%8.45B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 24.28%11.89B-6.69%8.48B17.28%30.94B0.82%4.78B13.24%9.56B21.01%7.5B30.02%9.09B24.85%26.38B18.00%4.74B38.72%8.45B
Gross dividend payment
Basic earnings per share 24.26%52.09-6.70%37.1817.29%135.610.82%20.9513.27%41.9221.01%32.8930.02%39.8524.85%115.6218.00%20.7838.69%37.01
Diluted earnings per share 24.28%51.95-6.67%37.0817.28%135.210.77%20.8813.25%41.821.03%32.830.01%39.7324.85%115.2918.00%20.7238.73%36.91
Dividend per share 0022.73%2725.00%15020.00%12022.22%2214.29%120
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More